Evidence map›Paper›PMID 42292765›Full record

ArticleThe World Allergy Organization journal2026

Why physicians underuse patient-reported outcomes in atopic dermatitis and chronic urticaria - Insights from the UCARE/ADCARE PROMUSE study.

Ivan Cherrez-Ojeda, Karla Robles-Velasco, Ana Giménez-Arnau, Kiran Godse, Dorota Krasowska, Joanna Bartosińska, Paulina Szczepanik-Kułak, Bartłomiej Wawrzycki, Pavel Kolkhir, Anastasiia Allenova and 56 more

Abstract read
In one paragraph

Article in The World Allergy Organization journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

66 authors.

Ivan Cherrez-OjedaInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Karla Robles-VelascoUniversidad Espiritu Santo, Samborondon, Ecuador.
Ana Giménez-ArnauDepartment of Dermatology, Hospital del Mar, IMIM, Universität Pompeu Fabra, Barcelona, Spain.
Kiran GodseDepartment of Dermatology, D Y. Patil University School of Medicine, Mumbai, India.
Dorota KrasowskaDepartment of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, Lublin, Poland.
Joanna BartosińskaDepartment of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, Lublin, Poland.
Paulina Szczepanik-KułakDepartment of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, Lublin, Poland.
Bartłomiej WawrzyckiDepartment of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, Lublin, Poland.
Pavel KolkhirInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Anastasiia AllenovaLaboratory of Immune-mediated Skin diseases, Institute of Regenerative Medicine, Biomedical Science & Technology Park, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
Andrey AllenovInstitute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
Sergey TkachenkoRussian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Natasa Teovska MitrevskaRemedika General Hospital Dermatology Department, Skopje, Republic of North Macedonia.
Dragan MijakoskiInstitute of Occupational Health of RN Macedonia, WHO CC, GA2LEN CC, Allergy Center, Skopje, Republic of North Macedonia.
Sasho StoleskiInstitute of Occupational Health of RN Macedonia, WHO CC, GA2LEN CC, Allergy Center, Skopje, Republic of North Macedonia.
Marta Kolacinska-FlontDepartment of Internal Medicine, Asthma and Allergy, Barlicki Memorial Hospital Medical University of Lodz, Poland.
Izabela Kuprys-LipinskaDepartment of Internal Medicine, Asthma and Allergy, Barlicki Memorial Hospital Medical University of Lodz, Poland.
Joanna MolinskaDepartment of Internal Medicine, Asthma and Allergy, Barlicki Memorial Hospital Medical University of Lodz, Poland.
Alicja Kasperska-ZającEuropean Centre for Diagnosis and Treatment of Urticaria/Angioedema (GA2LEN UCARE /ACARE Network) and Department of Clinical Allergology and Urticaria of Medical University of Silesia, Silesia, Poland.
Magdalena ZajacEuropean Centre for Diagnosis and Treatment of Urticaria/Angioedema (GA2LEN UCARE /ACARE Network) and Department of Clinical Allergology and Urticaria of Medical University of Silesia, Silesia, Poland.
Mateusz ZamlynskiEuropean Centre for Diagnosis and Treatment of Urticaria/Angioedema (GA2LEN UCARE /ACARE Network) and Department of Clinical Allergology and Urticaria of Medical University of Silesia, Silesia, Poland.
Florin MihaltanNational Institute of Pneumology, Bucharest, Romania.
Ruxandra UlmeanuARIA (Allergic Rhinitis and Its Impact on Asthma), Montpellier, France.
Anna Zalewska-JanowskaMedical University of Lodz, Psychodermatology and Neuroimmunobiology of the Skin Department, Lodz, Poland.
Katarzyna TomaszewskaMedical University of Lodz, Psychodermatology and Neuroimmunobiology of the Skin Department, Lodz, Poland.
Mona Al-AhmadMicrobiology Department, Faculty of Medicine, Kuwait University, Safat, Kuwait.
Maryam Ali Al-NesfAllergy and Immunology Division, Medicine Department, Hamad Medical Corporation, Doha, Qatar.
MSs AbhsAllergy and Immunology Division, Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Tayseer IbrahimAllergy and Immunology Division, Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Sami AgelAllergy and Immunology Division, Medicine Department, Hamad Medical Corporation, Doha, Qatar.
David PesquéDepartment of Dermatology, Hospital del Mar, Barcelona, Spain.
Mónica Rodríguez-GonzálezHospital Español de México, Ciudad de México, México City, México.
Guillermo Hideo Wakida-KuzunokiColegio Mexicano de Pediatras Especialistas en Inmunología Clínica y Alergia, México.
German D RamonInstituto de Alergia e Inmunología del Sur, GA2LEN UCARE/Adcare/ACARE Centre, Bahia Blanca, Buenos Aires, Argentina.
Gonzalo N RamonInstituto de Alergia e Inmunología del Sur, GA2LEN UCARE/Adcare/ACARE Centre, Bahia Blanca, Buenos Aires, Argentina.
Sophia NeisingerColegio Mexicano de Pediatras Especialistas en Inmunología Clínica y Alergia, México.
Hanna BonnekohColegio Mexicano de Pediatras Especialistas en Inmunología Clínica y Alergia, México.
Maia RukhadzeCentre Allergy & Immunology, Tbilisi, Georgia.
Maryam KhoshkhuiAllergy Research Centre, Mashhad University of Medical Science(MUMS), Mashhad, Iran.
Mehraneh Movahedi AliabadiAllergy Research Centre, Mashhad University of Medical Science(MUMS), Mashhad, Iran.
Daria FominaMoscow Practical and Research Centre of Allergy and Immunology, Clinical City Hospital, Moscow, Russian Federation.
Désirée Larenas-LinnemannHospital Médica Sur, México City, México.
Mitja KošnikAllergy University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
Rabia Oztas KaraDepartment of Dermatology, Sakarya University Faculty of Medicine, Sakarya, Turkey.
Chrystopherson Gengyny Caballero LópezUniversidad Autónoma de Puebla, Hospital Universitario de Puebla, Servicio de Alergia e Inmunología Clínica, Puebla, Puebla, México.
Qiang LiuSecond Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China.
Juan Carlos IvancevichServicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires, Argentina.
Luis Felipe EnsinaDivision of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo and CP Alpha Clinical Research Centre, São Paulo, Brazil.
Nelson RosarioUrticaria Centre of Reference and Excellence (UCARE), Federal University of Parana, Rua General Carneiro, Curitiba, Brazil.
Violeta KvedarieneInstitute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Institute of Clinical Medicine, Clinic of Chest Diseases, Immunology and Allergology, Vilnius, Lithuania.
Moshe Ben-ShoshanDivision of Pediatric Allergy, Immunology and Dermatology, Department of Pediatrics, McGill University Health Center, Montreal, Quebec, Canada.
Roberta Fachini Jardim CriadoFaculdade de Medicina do ABC (FMABC), Santo André (SP), Brazil.
Andrea BauerDepartment of Dermatology, University Allergy Centre, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany.
Annia CherrezDepartment of Dermatology, Allergology and Venereology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Herberto Chong-NetoDepartment of Pediatrics, Hospital de Clínicas, Federal University of Parana (UFPR), Curitiba, Brazil.
Maria Isabel Rojo-GuierrezHospital Juarez De México, México City, México.
Michael RudenkoLondon Allergy and Immunology Centre, London, United Kingdom.
José Ignacio Larco SousaClinica San Felipe, Lima, Peru.
Aleksandra LesiakDepartment of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Poland.
Edgar MatosInstituto Nacional de Salud del Nino, Lima, Peru.
Nelson MuñozSpecialist Centre: Muñoz Alergias y Pediatría, Riobamba, Ecuador.
Jaime MorenoCentro Particular de Alergias, Ecuador.
Ivan TinocoCentro de Alergia Tinoco, Machala, Ecuador.
Marco Faytong-HaroFacultad de Investigación, Universidad Estatal de Milagro, Milagro, Guayas, Ecuador.
Jean BousquetColegio Mexicano de Pediatras Especialistas en Inmunología Clínica y Alergia, México.
Torsten ZuberbierColegio Mexicano de Pediatras Especialistas en Inmunología Clínica y Alergia, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The recently published PROMUSE study performed by the GA Methods: This is an observational, cross-sectional study where the PROMUSE questionnaire was used and applied to physicians from 45 specialized centers worldwide. Of the 2534 physicians surveyed in the PROMUSE study, 474 who treated patients with AD and CU were included in the analysis. Results: For the 474 physicians who treat AD and CU patients, the most common issues perceived as primary barriers to PROM use were "time constraints" (n = 455/474), "not mandated to complete" (n = 428/474), and "patients dislike PROMs" (n = 425/474). Higher rates of barrier perception were observed for males, younger physicians, and non-specialist physicians. The more barriers physicians perceive, the less frequently PROMs are used, with a strong and significant negative correlation between the number of barriers perceived and the frequency of PROM use. Two of the 15 perceived barriers significantly prevented using PROMs: the belief that PROMs constrain the doctor-patient relationship and the belief that patients dislike them. Conclusions: The underutilization of PROMs in AD and CU is strongly driven by physicians' perceptions that patients dislike them and that they constrain the doctor-patient relationship. This suggests physicians may have deeper insights into the practical shortcomings of current instruments. Therefore, rather than solely focusing on physician education, existing AD and CU PROMs urgently require re-evaluation and co-development with direct patient involvement (eg, Core Outcome Sets) to ensure they are genuinely patient-centered and clinically relevant.

Indexed as

Atopic dermatitisBarriersChronic urticariaDermatologyPatient-reported outcome measures

Identifiers

PMID42292765
PMCPMC13264230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.